Ben Tre Pharmaceutical Joint Stock Company (HOSE: DBT)
Health Care · Pharmaceuticals · VN
₫13,150.00
-0.75% today · +16.3% 1Y
Ben Tre Pharmaceutical Joint Stock Company (HOSE: DBT) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $11.06M.
Over the last twelve months the share price has gained 16.3%, trading between 9.99K and 13.90K.
Tweenvest scores Ben Tre Pharmaceutical Joint Stock Company across four factors: quality 50/100, value 35/100. Its strongest factor is quality.
DBT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $11.06M
- Revenue (TTM)
- $33.18M
- P/E
- 10.71
- EPS
- 1,227.52
- Dividend yield
- —
- Beta (5Y)
- 0.34
- 52-week high
- ₫13,900.00
- 52-week low
- ₫9,990.00
- Avg volume (3M)
- —
- Shares outstanding
- 21.97M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,239.32 | -0.61% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.18 | +0.05% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.08 | +3.60% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.37 | +1.41% |
Figures last refreshed Aug 18, 2026.